Beauty Health SKIN shares are trading higher on Tuesday after the company reported better-than-expected Q4 results.
The company reported adjusted quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04. The company also reported quarterly sales of $98.13 million which beat the analyst consensus estimate of $94.61 million.
“We achieved strong annual sales growth, launched Hydrafacial Syndeo, our innovative next generation delivery system, and continued to build the world's premiere skincare booster portfolio," said BeautyHealth President and Chief Executive Officer Andrew Stanleick.
Beauty Health sees FY23 sales of $450 million to $470 million and reiterates EBITDA margin of 18% - 20%.
"We enter 2023 from a position of strength, having invested to expand our global capabilities and scale. As planned, we are now turning our focus to driving profitable growth and flawlessly executing our international Syndeo launch in the second quarter," Andrew Stanleick continued.
Health Beauty Life is a lifestyle media outlet that offers print, video, online, and emerging media with content about health, beauty, fashion, fitness, travel, and non-profit charity organizations, as well as other topics of interest.
SKIN Price Action: Beauty Health has a 52-week high of $20.49 and a 52-week low of $8.25.
Beauty Health shares are up 10.9% at $12.55 at the time of publication, according to Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.